As a network of experts in our field, we believe coming together is the key to accelerating research.

hyperCORE International offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas.  Our network features over 100 research site locations across North and South America, multiple hospital affiliations, remote and mobile units, and expertise in device and therapeutics of all phases of research.  Our partner sites have special expertise and key opinion leaders in endocrine and metabolic studies inclusive of NASH and have on-site FibroScan® machines in many of our locations.  They are leading industry representatives in vaccine research inclusive of the Clinical Trial Site of the Year for Vaccine Research, and also have large dermatology expertise with access to more than 1 million patient lives and various medical indications to offer research as a pathway to clinical care.

Our ability to move beyond the constraints and challenges is reflected in our robust clinical trial experience.  We have collectively administered 10,000+ COVID-19 tests and contributed an estimated 10% of study volunteers towards vaccines.  Our patients are exceptionally diverse in health status, age, race, ethnicity, sex, and co-morbidities.  We have enabled our sites to scale quickly to accommodate large volume trials by using shared resources and platforms resulting in rapid study start-up delivery and execution; research has never been more streamlined.